Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Coronavirus Disease-2019: Implication for the care and management of patients with systemic lupus erythematosus.

Literature DB >> 32352359

Coronavirus Disease-2019: Implication for the care and management of patients with systemic lupus erythematosus.

Abstract

Systemic lupus erythematosus is a chronic remitting-relapsing autoimmune disease that affects multiple organ systems. In this article we discuss aspects in the management of lupus patients that are particularly relevant during the current SARS-CoV-2 pandemic. We speculate that lupus patients might be more susceptible for a more severe COVID-19 disease course and emphasize the importance of maintaining remission in lupus patients. We discuss the critical role hydroxychloroquine plays in the management of lupus patients and suggest considering the psychosocial implications of the current pandemic on lupus care.

Entities: Chemical Disease Species

Year: 2020 PMID： 32352359 PMCID： PMC7431343 DOI： 10.5152/eurjrheum.2020.20055

Source DB: PubMed Journal: Eur J Rheumatol ISSN： 2147-9720

36 in total

Review 1. Pulmonary Complications of Systemic Lupus Erythematosus.

Authors: Jennifer R Hannah; David P D'Cruz
Journal: Semin Respir Crit Care Med Date: 2019-05-28 Impact factor: 3.119

Review 2. Hydroxychloroquine use in the Baltimore Lupus Cohort: effects on lipids, glucose and thrombosis.

Authors: M Petri
Journal: Lupus Date: 1996-06 Impact factor: 2.911

3. A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus.

Authors:
Journal: N Engl J Med Date: 1991-01-17 Impact factor: 91.245

4. Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort.

Authors: Guillermo J Pons-Estel; Graciela S Alarcón; Gerald McGwin; Maria I Danila; Jie Zhang; Holly M Bastian; John D Reveille; Luis M Vilá
Journal: Arthritis Rheum Date: 2009-06-15

5. Epigenetic Reprogramming in Naive CD4+ T Cells Favoring T Cell Activation and Non-Th1 Effector T Cell Immune Response as an Early Event in Lupus Flares.

Authors: Patrick Coit; Mikhail G Dozmorov; Joan T Merrill; W Joseph McCune; Kathleen Maksimowicz-McKinnon; Jonathan D Wren; Amr H Sawalha
Journal: Arthritis Rheumatol Date: 2016-09 Impact factor: 10.995

6. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors: Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal: Lancet Date: 2020-01-24 Impact factor: 79.321

7. Effective treatment of severe COVID-19 patients with tocilizumab.

Authors: Xiaoling Xu; Mingfeng Han; Tiantian Li; Wei Sun; Dongsheng Wang; Binqing Fu; Yonggang Zhou; Xiaohu Zheng; Yun Yang; Xiuyong Li; Xiaohua Zhang; Aijun Pan; Haiming Wei
Journal: Proc Natl Acad Sci U S A Date: 2020-04-29 Impact factor: 11.205

8. COVID-19: consider cytokine storm syndromes and immunosuppression.

Authors: Puja Mehta; Daniel F McAuley; Michael Brown; Emilie Sanchez; Rachel S Tattersall; Jessica J Manson
Journal: Lancet Date: 2020-03-16 Impact factor: 79.321

9. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.

Authors: Philippe Gautret; Jean-Christophe Lagier; Philippe Parola; Van Thuan Hoang; Line Meddeb; Morgane Mailhe; Barbara Doudier; Johan Courjon; Valérie Giordanengo; Vera Esteves Vieira; Hervé Tissot Dupont; Stéphane Honoré; Philippe Colson; Eric Chabrière; Bernard La Scola; Jean-Marc Rolain; Philippe Brouqui; Didier Raoult
Journal: Int J Antimicrob Agents Date: 2020-03-20 Impact factor: 5.283

10. In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).

Authors: Xueting Yao; Fei Ye; Miao Zhang; Cheng Cui; Baoying Huang; Peihua Niu; Xu Liu; Li Zhao; Erdan Dong; Chunli Song; Siyan Zhan; Roujian Lu; Haiyan Li; Wenjie Tan; Dongyang Liu
Journal: Clin Infect Dis Date: 2020-07-28 Impact factor: 9.079

14 in total

1. Recommendations for the management of patients with immune-mediated kidney disease during the severe acute respiratory syndrome coronavirus 2 pandemic.

Authors: Hans-Joachim Anders; Annette Bruchfeld; Gema Maria Fernandez Juarez; Jürgen Floege; Dimitrios Goumenos; Kultigin Turkmen; Cees van Kooten; Vladimir Tesar; Mårten Segelmark
Journal: Nephrol Dial Transplant Date: 2020-06-01 Impact factor: 5.992

Review 2.

Authors: Timo Buhl; Stefan Beissert; Evelyn Gaffal; Matthias Goebeler; Michael Hertl; Cornelia Mauch; Kristian Reich; Enno Schmidt; Michael P Schön; Michael Sticherling; Cord Sunderkötter; Claudia Traidl-Hoffmann; Thomas Werfel; Dagmar Wilsman-Theis; Margitta Worm
Journal: J Dtsch Dermatol Ges Date: 2020-08 Impact factor: 5.584

Review 3. Autoimmune connective tissue diseases in the COVID-19 pandemic.

Authors: Lyubomir Dourmishev; Dimitrina Guleva; Joana Pozharashka; Kossara Drenovska; Lyubka Miteva; Snejina Vassileva
Journal: Clin Dermatol Date: 2020-12-15 Impact factor: 3.541

4. Systemic lupus erythematosus manifestation following COVID-19: a case report.

Authors: Batool Zamani; Seyed-Masoud Moeini Taba; Mohammad Shayestehpour
Journal: J Med Case Rep Date: 2021-01-25

Review 5. SARS-CoV-2 and Systemic Lupus Erythematosus.

Authors: Aikaterini Thanou; Amr H Sawalha
Journal: Curr Rheumatol Rep Date: 2021-01-28 Impact factor: 4.592

6. Digital Approaches to Remote Pediatric Health Care Delivery During the COVID-19 Pandemic: Existing Evidence and a Call for Further Research.

Authors: Sherif M Badawy; Ana Radovic
Journal: JMIR Pediatr Parent Date: 2020-06-25